Results 21 to 30 of about 14,172 (249)

Clinical features of varicella-zoster virus infection [PDF]

open access: yes, 2018
Varicella-zoster virus (VZV) is a pathogenic human herpes virus that causes varicella (chickenpox) as a primary infection, following which it becomes latent in peripheral ganglia.
Gershon, Anne A., Kennedy, Peter G.E.
core   +1 more source

The Effectiveness of Various Types of Electrical Stimulation of the Spinal Cord for Chronic Pain in Patients with Postherpetic Neuralgia: A Literature Review

open access: yesPain Research and Management, 2023
Introduction. Postherpetic neuralgia (PHN) is a severe condition that remains a challenge to treat. Spinal cord stimulation (SCS) is used in cases of insufficient efficacy of conservative treatment.
Emil Isagulyan   +7 more
doaj   +1 more source

Differential myelinated and unmyelinated sensory and autonomic skin nerve fiber involvement in patients with ophthalmic postherpetic neuralgia

open access: yesFrontiers in Neuroanatomy, 2015
Postherpetic neuralgia is a common and exceptionally drug-resistant neuropathic pain condition. In this cross-sectional skin biopsy study, seeking information on the responsible pathophysiological mechanisms we assessed how ophthalmic postherpetic ...
Andrea eTruini   +8 more
doaj   +1 more source

Universal Health Coverage for Schizophrenia: A Global Mental Health Priority. [PDF]

open access: yes, 2015
The growing momentum towards a global consensus on universal health coverage, alongside an acknowledgment of the urgency and importance of a comprehensive mental health action plan, offers a unique opportunity for a substantial scale-up of evidence-based
Patel, Vikram
core   +2 more sources

Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study

open access: yesThe Lancet Public Health, 2018
Background: In 2013, a herpes zoster vaccination programme was introduced in England for adults aged 70 years with a phased catch-up programme for those aged 71–79 years.
Gayatri Amirthalingam, MFPH   +6 more
doaj   +1 more source

Clinical and psychosocial correlates of post-herpetic neuralgia [PDF]

open access: yes, 2008
Post-herpetic neuralgia is the most challenging and debilitating complication of herpes zoster in the immunocompetent host. Because the effect of treatment is disappointing once the syndrome has developed, it is important to know which factors predict ...
Bellino, S   +5 more
core   +1 more source

Specific down-regulation of spinal μ-opioid receptor and reduced analgesic effects of morphine in mice with postherpetic pain [PDF]

open access: yes, 2006
The analgesic effects of opioid agonists and the expression of μ-and κ-opioid receptors were compared between mice with herpetic pain and those with postherpetic pain induced by herpetic virus inoculation.
Kuraishi Yasushi   +3 more
core   +2 more sources

Topical treatment of peripheral neuropathic pain: applying the evidence [PDF]

open access: yes, 2017
Patients with peripheral neuropathic pain (NP) may only achieve partial pain relief with currently recommended first-line oral treatments, which are also associated with systemic adverse events.
Cruccu, Giorgio, Sommer, Claudia
core   +1 more source

Pregabalin alleviates postherpetic neuralgia by downregulating spinal TRPV1 channel protein [PDF]

open access: yes, 2021
Purpose: To determine the mechanism involved in pregabalin-induced alleviation of postherpetic neuralgia in a rat model.Methods: Ninety-sixty healthy Sprague-Dawley (SD) rats were assigned to sham, model andpregabalin groups (32 rats per group).
He, Yunwu   +6 more
core   +2 more sources

Recurrent herpes zoster with segmental paresis and postherpetic neuralgia [PDF]

open access: yesVojnosanitetski Pregled, 2014
Introduction. Postherpetic neuralgia and segmental paresis represent rare complications of herpes zoster infection. Recurrent herpes zoster is also rare and occurs within the first 3 years of the begining of the illness in only 1.4% of cases but
Martić Vesna
doaj   +1 more source

Home - About - Disclaimer - Privacy